Innovation Empowers Global Expansion | VitaiMed Concludes a Successful Show at the 94th CMEF Autumn Exhibition in Beijing

The 94th China International Medical Equipment Fair (CMEF Autumn Session) drew to a successful close at the Capital International Convention & Exhibition Center. Centered on the theme “An Open China for a Healthy World”, this exhibition brought together global players from the medical‑industry ecosystem and built an integrated exchange platform linking government, industry, academia, research, investment, end‑users and service providers.

VitaiMed made a high‑profile appearance with its comprehensive product portfolio covering urinary incontinence care, urological ostomy care, peritoneal dialysis, CRRT, TPN infusion, pre‑filled syringes and the ViNurse® intelligent care system. Building on the milestone achievement of securing US FDA registration for its full product line, VitaiMed officially announced its full‑scale return to the US market. Supported by robust product innovation capabilities, global compliance deployment and smart‑care solutions, the company earned high recognition from domestic and overseas customers, clinical specialists and industry partners, marking a highly fruitful participation in the show.

During the exhibition, VitaiMed’s booth remained bustling with visitors. The team received representatives from domestic medical institutions at all levels, distributors and industrial investors, as well as overseas purchasers and regulatory consultants from the United States, Europe, Latin America, the Middle East, Southeast Asia and other regions.

The brand showcased its brand‑new urinary‑incontinence product series, a complete range of consumables for adult incontinence applicable to diverse scenarios including hospital clinical settings, long‑term home‑based care and senior‑care facilities. Complementing its existing ostomy, nephrology and critical‑care nutrition product lines, this offering forms a closed‑loop solution for chronic‑disease long‑term care.

The team also displayed physical samples of its full‑range medical consumables and gave live demonstrations of the digital capabilities of the ViNurse® intelligent care system for home dialysis, incontinence management, elderly care and continuous in‑hospital and out‑of‑hospital care. The demonstrations vividly illustrated the company’s integrated strengths spanning single‑use medical consumables and remote intelligent‑care platforms.

As a medical‑device enterprise deeply rooted in urology, nephrology and critical‑care tracks, VitaiMed pursues dual‑driven growth through domestic innovation and global expansion. The company consistently benchmarks against international standards and advances registrations for NMPA (China), US FDA, EU MDR, Brazil Anvisa, Peru Digemid and other jurisdictions.

Successful FDA registration for its complete product range signifies that VitaiMed’s product quality, manufacturing systems and quality‑control processes meet US market‑access requirements, paving the way for channel development and clinical promotion across the United States. Meanwhile, VitaiMed continues to participate in leading international exhibitions such as Medica and PhilMedical Expo, delivering high‑quality care consumables and digital care solutions for worldwide markets.

At this Beijing‑based CMEF edition, multiple letters of intent for cooperation were reached covering domestic channel expansion, regional overseas agency partnerships for the US and other markets, as well as strategic collaboration in smart elderly‑care and telemedicine, laying solid groundwork for subsequent market roll‑outs.

Chen Wei, CEO of VitaiMed, commented:

“CMEF serves as a vital gateway connecting Chinese medical innovations with global markets. We focus on high‑demand long‑term‑care segments including incontinence care, ostomy management, dialysis, critical care and nutritional support. On one hand, we keep refining consumable manufacturing processes and strictly enforce quality and compliance standards. Today we celebrate a major milestone: full FDA registration for VitaiMed’s complete product portfolio and our full‑scale return to the US market. On the other hand, we leverage ViNurse® to connect physical consumables with digital online management, addressing real‑world pain points in home‑based chronic‑disease care. Going forward, rooted in the innovation ecosystem of the G60 Science and Innovation Corridor in the Yangtze River Delta, VitaiMed will persist in technological innovation and global product roll‑out, bringing premium care products and smart solutions to more patients and families across the globe.”

This exhibition constituted both a comprehensive display of VitaiMed’s innovative achievements and compliance strengths, and a major public announcement of the brand’s re‑entry into global medical markets, including the United States. As the exhibition concludes, a new journey begins. Building on its fruitful CMEF participation and the new milestone of FDA registration, VitaiMed will continue to focus on clinical needs, accelerate new‑product R&D and complete regulatory registrations across global territories. Working hand‑in‑hand with industry‑chain partners, the company will contribute to Healthy China initiatives and empower high‑quality development of medical‑care services worldwide.